Arlington Capital Management, Inc. Astrazeneca PLC Transaction History

Arlington Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$35.49 - $43.02 $1.89 Million - $2.29 Million	-53,202 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$36.86 - $41.49 $197,975 - $222,842	-5,371 Reduced 9.17%	53,202 $2.02 Million
Q3 2018 Nov 07, 2018	SELL	$34.76 - $39.72 $265,809 - $303,738	-7,647 Reduced 11.55%	58,573 $2.32 Million
Q2 2018 Aug 09, 2018	SELL	$34.55 - $37.05 $109,177 - $117,077	-3,160 Reduced 4.55%	66,220 $2.33 Million
Q1 2018 May 07, 2018	BUY	$32.97 - $36.63 $2.29 Million - $2.54 Million	69,380 New	69,380 $2.43 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Arlington Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Arlington Capital Management, Inc. with notifications on news.